Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 2
2011 1
2013 1
2015 2
2016 2
2017 1
2018 1
2019 2
2020 3
2021 3
2022 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Checkpoint Inhibitor-Induced Colitis.
Bellaguarda E, Hanauer S. Bellaguarda E, et al. Am J Gastroenterol. 2020 Feb;115(2):202-210. doi: 10.14309/ajg.0000000000000497. Am J Gastroenterol. 2020. PMID: 31922959 Review.
Reply.
Bellaguarda E, Sakuraba A. Bellaguarda E, et al. Clin Gastroenterol Hepatol. 2016 May;14(5):776-7. doi: 10.1016/j.cgh.2016.02.002. Epub 2016 Feb 4. Clin Gastroenterol Hepatol. 2016. PMID: 26853161 No abstract available.
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
Bressler B, Yarur A, Silverberg MS, Bassel M, Bellaguarda E, Fourment C, Gatopoulou A, Karatzas P, Kopylov U, Michalopoulos G, Michopoulos S, Navaneethan U, Rubin DT, Siffledeen J, Singh A, Soufleris K, Stein D, Demuth D, Mantzaris GJ. Bressler B, et al. Among authors: bellaguarda e. J Crohns Colitis. 2021 Oct 7;15(10):1694-1706. doi: 10.1093/ecco-jcc/jjab058. J Crohns Colitis. 2021. PMID: 33786600 Free PMC article.
Primary Signet Ring Cell Carcinoma of the Ileal Pouch.
Tetangco EP, Krogh K, Yang GY, Bellaguarda E. Tetangco EP, et al. Among authors: bellaguarda e. ACG Case Rep J. 2022 Jan 10;9(1):e00713. doi: 10.14309/crj.0000000000000713. eCollection 2022 Jan. ACG Case Rep J. 2022. PMID: 35028322 Free PMC article.
Recurrent brisk haematochezia in a patient with quiescent Crohn's disease.
Gasanova Z, Lemmer A, Bellaguarda E. Gasanova Z, et al. Among authors: bellaguarda e. Frontline Gastroenterol. 2020 Feb 19;12(5):447-448. doi: 10.1136/flgastro-2019-101404. eCollection 2021. Frontline Gastroenterol. 2020. PMID: 35401956 Free PMC article. No abstract available.
28 results